F. Jorquera et al., ANTIPYRINE CLEARANCE IN SURGICAL PATIENTS MAINTAINED ON HYPOCALORIC PERIPHERAL PARENTERAL-NUTRITION, JPEN. Journal of parenteral and enteral nutrition, 18(6), 1994, pp. 544-548
Background: Antipyrine clearance (CL(AP)) constitutes a sensitive indi
cator of hepatic microsomal enzyme activity providing specific informa
tion on hepatic function. The purpose of this study was to evaluate th
e influence of hypocaloric peripheral parenteral nutrition on CL(AP) i
n patients receiving nutrition support after elective surgery. Methods
: CL(AP) was measured in 15 patients before elective gastrointestinal
surgery and 6 days after the surgery. Antipyrine (1 g) was administere
d orally, and CL(AP) was determined by the one-sample method. Subjects
received a postoperative 786 kcal/d regimen providing 66 g of amino a
cid per day and 133 g of glucose per day for 5 days. Nutritional statu
s was evaluated by anthropometric parameters. A control group of 15 pa
tients received no postoperative hypocaloric peripheral parenteral nut
rition but received conventional fluid therapy Results: Mean CL(AP) wa
s increased by 61% (0.66 +/- 0.06 mL/min.kg(-1) body wt vs 0.41 +/- 0.
05 mL/min.kg(-1) body wt in the preoperative period; p <.001), and ant
ipyrine half-life was reduced by 42% (10.9 +/- 1.0 hours vs 18.9 +/- 2
.0 hours; p <.001) after 5 days of hypocaloric peripheral parenteral n
utrition. No significant modification was shown among control patients
in CL(AP) (0.54 +/- 0.07 mL/min.kg(-1) body wt vs 0.46 +/- 0.05 mL/mi
n.kg(-1) body wt in the preoperative period) or in antipyrine half-lif
e (14.0 +/- 1.4 hours vs 16.5 +/- 1.8 hours). No significant correlati
on was observed between CL(AP) changes and those for the nutritional s
tatus of the patients. Conclusions: The results of our study indicate
that oxidative drug-metabolizing capacity is increased in surgical pat
ients maintained on hypocaloric peripheral parenteral nutrition. Clini
cians should be conscious of the potential of this effect for altering
the efficacy or toxicity of many therapeutic agents.